I-123 Biomarker Committee: Difference between revisions
Jump to navigation
Jump to search
m →Round 6 |
No edit summary |
||
| Line 2: | Line 2: | ||
:Co-chairs: John Dickson, PhD; John Seibyl, MD | :Co-chairs: John Dickson, PhD; John Seibyl, MD | ||
:Secretary: Julie Lisiecki | :Secretary: Julie Lisiecki | ||
* [http://tinyurl.com/QIBA-SPECT-Roster Roster] | * [http://tinyurl.com/QIBA-SPECT-I-123-Roster Roster to be posted] | ||
Revision as of 15:04, 22 May 2019
- Co-chairs: John Dickson, PhD; John Seibyl, MD
- Secretary: Julie Lisiecki
Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases
Recent Meetings/Call Summaries
Profile Development
Reference Materials
- QIBA SPECT I-123 Biomarker Committee Presentation (11.16.2018) John Seibyl, MD